Is Cabozantinib Really Better Than Sunitinib As First-Line Treatment of Metastatic Renal Cell Carcinoma?

出版年份 2017 全文链接

标题

Is Cabozantinib Really Better Than Sunitinib As First-Line Treatment of Metastatic Renal Cell Carcinoma?

作者

关键词

-

出版物

JOURNAL OF CLINICAL ONCOLOGY

Volume 35, Issue 16, Pages 1858-1859

出版商

American Society of Clinical Oncology (ASCO)

发表日期

2017-04-05

DOI

10.1200/jco.2016.71.6506

向作者/读者发起求助以获取更多资源

Protocol

Reagent

Reprint

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

© Peeref 2019-2024. All rights reserved.